Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Oxytocin as Adjunctive Therapy for the Treatment of Schizophrenia: a Randomized, Double Blind Trial

NCT01699997 is registered in ClinicalTrials.gov with IRCCS Centro San Giovanni di Dio Fatebenefratelli as lead sponsor.

NCT NCT01699997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01699997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Oxytocin as Adjunctive Therapy for the Treatment of Schizophrenia: a Randomized, Double Blind Trial
Lead sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
November 30, 2015
Enrollment
32 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia